SERPIN B3/B4, members of the serpin superfamily, are fundamental for the control of proteolysis through a known inhibitory function of different proteases. Several studies have documented an important role of SERPIN B3 in the modulation of inflammation, programmed cell death and fibrosis. To confirm the role of SERPIN B3 in lung fibrosis and overall investigate its influence on epithelial dysfunction, a stratified controlled trial randomly assigning bleomycin (BLM) treatment was performed on both SERPIN B3 transgenic (TG) and wild-type (WT) mice. TG and WT animals were killed 48 h (group T48 h) and 20 days (group T20d) after BLM treatment. Lung fibrosis was assessed by histology and hydroxyproline measurement. Architectural remodeling, inflammation, epithelial apoptosis and proliferation were quantified. Moreover, the profibrogenetic cytokine transforming growth factor (TGF)-b, cathepsin K, L and S were also investigated. No significant differences were observed between TG and WT mice of group T48 h in any parameters. In group T20d, less inflammation and a significant increase in epithelial proliferation were detected in treated TG than WT mice despite a similar apoptotic index, thus resulting in a different apoptosis/proliferation imbalance with a significant gain of epithelial proliferation. Moreover, TG mice showed higher TGF-b expression and more extended fibrosis. General linear model analysis, applied on morphological data, showed that interaction between SERPIN B3 expression and treatment was mainly significant for fibrosis. This study provides in vivo evidence for a role of SERPIN B3 in inhibiting inflammation and favoring epithelial proliferation with increased TGF-b secretion and thus the likelihood of consequent fibrogenesis.
Idiopathic pulmonary fibrosis (IPF), with its histopathological signature of usual interstitial pneumonia, is a devastating form of interstitial lung disease of unknown etiology. The pathogenesis of pulmonary fibrosis is poorly understood and has been the subject of many investigations. Historically, inflammation has been viewed as central to the pathogenesis of IPF. 1 A recent paradigm shift proposes a model in which injury to the epithelium initiates a proinflammatory and profibrotic cascade, resulting in fibroblast expansion and progressive fibrosis reminiscent of abnormal wound healing. 2 An increased body of evidence now recognizes epithelial apoptosis as an important early feature in IPF 3 and in murine models of bleomycin (BLM)-induced lung fibrosis. 4 After injury epithelial repair has a pivotal role in normal wound-healing processes. 5 Abnormal re-epithelization with aberrant proliferation of metaplastic cells (bronchial, squamous and cuboidal) is another important aspect frequently observed in highly remodeled fibrotic areas of IPF lungs as honeycomb lesions.
A higher proliferation index and epithelial dysplasia have frequently been detected in honeycomb: these areas represent a site of high instability at risk of neoplastic transformation. 6 An increased incidence of carcinomas, such as squamous cell carcinoma and adenocarcinoma, mainly located in peripheral lung areas, has been reported in IPF patients. [7] [8] [9] Whether the appearance of abnormal epithelial cells protects or promotes fibrosis remains uncertain. 10 Several experimental and human studies reported a pro-fibrogenetic influence of metaplastic epithelial cells through the secretion of factors favoring fibrotic processes. 11, 12 More extensive lung fibrosis has recently been reported in IPF lungs with metaplastic epithelial cells that showed an overproduction of squamous cell carcinoma antigen (SCCA) and transforming growth factor (TGF)-b. 13 In that study, the influence of SCCA on favoring epithelial TGF-b secretion was also corroborated by an in vitro model. 13 SCCA 1 and 2, renamed according to the new nomenclature guidelines as SERPIN B3 and B4, 14 inhibit several types of proteases. A large amount of biochemical and biophysical information reveals that serpins are 'suicide' or 'single use' inhibitors that use a unique and extensive conformational change to inhibit proteases. 15 SERPIN B3 (SCCA 1) displays inhibitory activities on serine proteinase, for example, chymotrypsin, and cysteine proteinase, such as cathepsin L, K, S and papain, whereas SERPIN B4 (SCCA 2) inhibits serine proteinases, such as cathepsin G, human mast cell chymase and cysteine proteinases (eg, Der p1 and Der f1). 16 Several in vitro and in vivo studies have documented an important role of SERPIN B3 in the modulation of programmed cell death by different mechanisms, both in inflammatory and neoplastic processes. 17 To understand the role of SERPIN B3 in lung epithelial proliferation and its influence on architectural remodeling (AR) (inflammation and fibrosis), a stratified controlled trial was randomly performed assigning BLM treatment to both SERPIN B3 transgenic and wild-type mice (TG and WT, respectively).
BLM-induced pneumopathy in mice is a well-known animal model of lung injury and fibrosis. Significant epithelial loss through apoptotic cell death has been reported as an early event after BLM treatment. 18 To further detect the early and late influence of SERPIN B3 in BLM lung injury, the animals were killed at 48 h and 20 days after treatment.
SUBJECTS AND METHODS Animal Models
The study was carried out on 30 C57BL/6 mice transgenic for human SERPIN B3. Human SERPIN B3 cDNA (À7/ þ 1238) 19 was placed in the region downstream from the a1-antitripsin promoter and upstream from the bGH polyadenylation region. The whole construct was inserted in the plasmid pcDNA3 and injected into the pronucleus of fertilized eggs obtained from C57BL/6 mice.
The mice used for the experiments were 12-14 weeks old. Thirty age-matched C57BL/6 mice were used as controls.
Mice were all kept under specific pathogen-free conditions and maintained with free access to pellet food and water at the Animal Care Facility of the Experimental Surgery Division, University of Padua, Italy. Experiments were done in accordance with the Helsinki convention and institute guidelines and regulations. Immunoreactivity was visualized with 3-3 0 -diaminobenzidine (Dako). Sections were counterstained with hematoxylin for 1 min. Negative controls for nonspecific binding were processed omitting the primary antibodies, and revealed no signal.
TG Mice Characterization

BLM-Induced Lung Damage
Intratracheal instillation of BLM was performed in 40 mice (20 TG and 20 WT) . Briefly, BLM was dissolved at a concentration of 1.25 U/ml of sterile phosphate-buffered saline (PBS) and vortexed extensively before each 100-ml aliquot (2.5 U/kg) was used. The mice were anesthetized and intratracheal instillation was then performed slowly. Twenty animals were treated with PBS as the control group.
We killed 20 mice (10 TG and 10 WT) at 48 h after BLMtreatment to investigate the early changes because of BLMmediated injury. Both in vivo and in vitro studies have demonstrated that the highest apoptotic index (AI) was detected between 1 and 3 days after the treatment 20,21 and our 48-h time point has been chosen because it was exactly in the middle of the interval (group T48 h). To detect the late influence of SERPIN B3, 40 animals were killed 20 days after BLM or PBS treatment (group T20d) because the majority of experimental models showed at that time the most extended fibrotic remodeling. 22 At both times mice were weighed, anesthetized, heparinized and exsanguinated via the femoral artery. The heart and lungs were then removed en bloc. Lungs were inflated by intratracheal perfusion with PBS-buffered formaldehyde solution at a constant pressure of 20 mmH 2 O and then preserved in the solution for at least 24 h at room temperature. The lungs, sectioned parasagittally superior to inferior, were embedded in paraffin. Sections of 5 mm were prepared and stained with hematoxylin/eosin (H&E) and Azan-Mallory for morphological studies as previously described. 23 Morphological Analysis AR consisted of altered lung areas occupied by inflammation, fibrosis and vessel remodeling. Remodeled lung areas were selected by morphometrical software (Image Pro-plus V.5) in H&E stained sections and appeared as more condensed 'purple regions' (hematoxyphylic stained areas). In the histological panoramic view (1 Â -fold) magnification, the AR was calculated dividing the total AR extension by the total tissue area of the section (where n ¼ the number of fields): AR ¼ S nAR extension/total Area Â 100.
The extent of fibrosis and inflammation was evaluated respectively in Azan-Mallory and in H&E stained sections analyzing 10 random fields in the same section of imaged lesions at 50-fold magnification, excluding the areas of honeycombing and patrimonial peribronchiolar and septal fibrosis. In each selected field, the ratio of fibrotic and inflamed areas was calculated, dividing the total fibrotic and inflamed areas by the total tissue area of the section (where n ¼ the number of fields):
Fibrosis ratio ¼ Sn fibrotic area/total area Â 100. Inflammation ratio ¼ Sn inflamed area/total area Â 100
For each animal, the ratios obtained from the analyzed sections were then averaged. All parameters exclusively related to lung tissue (excluding air spaces) were measured to normalize the effect of collapse or expansion of lung tissue during sampling or tissue fixation. 13 
Determination of Hydroxyproline
The hydroxyproline (OH-Pro) content of mouse lung was determined by standard methods as previously described. 24 Briefly, after rinsing with PBS, the lung was defatted, dried, weighed and hydrolyzed for 22 h at 110 1C in 6 N HCl. Aliquots were then assayed by adding chloramine T solution for 20 min, 3.15 M perchloric acid for 5 min, and Erlich's reagent at 60 1C for 20 min. Absorbance was measured at 561 nm, and the amount of OH-Pro was determined against a standard curve. Results were expressed as percentage of collagen content (weight/weight) relative to dry weight of the tissue sample, considering that OH-Pro accounts for approximatively 11.8% of the amino acid content. 
Bronchiolar Metaplasia Grading
Alveolar metaplasia was identified as cells resembling bronchiolar epithelium lining normal or thickened alveolar walls. In all sections, an experienced pathologist (FC) graded each bronchiolization from I to IV using an appropriate grading system. 11 The presence of dysplasia of the metaplastic cells and neoplastic transformation were evaluated on the sections stained with H&E.
Immunohistochemistry for Proliferation Analysis
0 -diaminobenzidine (Dako). Negative controls for nonspecific binding were processed omitting the primary antibody and revealed no signal. Ki-67 immunostaining was randomly evaluated counting at least 100 nuclei. The percentage of positive nuclei was expressed as the proliferative index (PI).
Terminal Deoxynucleotidyltransferase-Mediated dUTP-Biotin Nick End-Labeling Method for Apoptotic Evaluation Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling method was used to investigate the presence of apoptosis. Sections were processed in accordance with Gavrieli's method. 25 Briefly, after deparaffinization and rehydration, sections were digested with proteinase K (Boehringer, Mannheim, Germany) at a concentration of 20 mg/ml for 15 min. The slides were then incubated with TdT/biotinylated dUTP diluted in buffer (Boehringer) and developed by using 3-3 0 -diaminobenzidine and 30 ml hydrogen peroxide. For negative controls, some slides were incubated in buffer without TdT or biotinylated UTP. For positive controls, some slides were incubated with 1 mg/ml DNAse (Sigma-Aldrich, Milan, Italy). The terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick endlabeling method positivity was randomly evaluated counting at least 100 nuclei. The percentage of positive nuclei was expressed as the AI.
Statistical Analysis
As the study investigated the role of SERPIN B3 in lung epithelial dysfunction, the results were obtained by comparing the morphologic alterations between WT and TG mice, by time of killing and treatment group. The quantitative variables evaluating the morphologic alterations are described by mean values and s.d., while for binary responses the proportion of events is expressed as percentage. The significance of the difference between mean values was obtained using the Mann-Whitney test, while the comparison between proportions was applied by means of Fisher's test. Taking into account the design effect of the study, a two-way analysis of variance was performed by applying the SAS PROC GLM (general linear models), general linear models were applied to evaluate the independent role of the covariates of SERPIN B3, treatment and their interaction on the morphological alterations.
The significance level was fixed at 0.05, and all tests were two-tailed. All the analyses were performed using the SAS statistical software rel. 9.1 (SAS Institute, Cary, NC, USA).
RESULTS
TG Mice Characterization
Evaluation of human SERPIN B3 homozygosis and tissue expression Homozygosis for the human SERPIN B3 gene was assessed by qualitative and quantitative PCR approaches: homozygous TG mice presented detectable threshold cycles (DCt: 1. 03 ± 0.01) and WT mice did not show amplification for the target gene. The analyses were performed in homozygous TG mice (Figure 1a) .
Human SERPIN B3 mRNAs were detectable by real-time RT-PCR in all the examined organs of all TG mice. The amount of transcripts was higher in the brain (22.2±11.0 pg/ mg RNA), lung (17.5±0.7 pg/mg RNA) and liver (11.2 ± 2.5 pg/mg RNA), while it was trivial in the genitals (6.0 ± 1.1 pg/mg RNA for testicle and 4.5 ± 1.1 pg/mg RNA for ovary), kidney and muscle (o0.6 pg/mg RNA) (Figure 1b) .
None of TG and WT mice lung tissues showed detectable levels of the mouse SERPIN B3 in the same experimental conditions. Specificity of all PCR products was confirmed by agarose gel electrophoresis (Figure 1c) . TG mice showed a strong immunostaining for human SERPIN B3, mainly detected in the cytoplasm of inflammatory cells (mainly macrophages). In the GroupT20d, SERPIN B3 was more evident as it was also expressed in metaplastic alveolar epithelial cells (Figures 2a and b) .
Morphological Analysis Group T48h
All the evaluated morphological parameters were hardly detected in control mice treated with PBS, with no statistical differences between the two groups (WT and TG).
No significant differences were found between WT and TG mice treated with BLM, also including AI.
Group T20d
The results of the morphological alterations in the mice after 20 days are shown in Table 1 by type (WT, TG) and treatment (PBS, BLM) group.
Considering PBS-treated mice, fibrosis and neoplastic transformations were never found in either WT or TG mice. Bronchiolization, AR and inflammation mean values were not significantly different between WT and TG, similarly to the AI. TG mice showed a higher mean value of PI than WT, although they did not reach the statistical significance (P ¼ 0.07).
In the BLM-treated group, AR mean value was not significantly different between WT and TG mice (23.1 ± 15.3% vs 16.8 ± 9.7%) (Figures 3a-c) .
TG mice presented more extended fibrosis than WT (25.5±15.7% vs 8.3±5.6%, P ¼ 0.01) (Figures 4a-d) .
The quantification of the OH-Pro content showed a higher value in BLM-treated mice than the control group (7.5±1.1% and 9.0±2.2% vs 6.0±2.3%, P ¼ 0.03 in both cases). TG mice showed a higher OH-Pro content than WT mice (9.0 ± 2.2% vs 7.5 ± 1.1%), although it was not statistically significant.
The two-way analysis of variance results, as performed by the GLM procedure, showed that interaction between SER-PIN B3 expression and treatment was significant for fibrosis (P ¼ 0.003), indicating that the presence of SERPIN B3 significantly increased the BLM effect on fibrosis. Real-time Cathepsin K levels were very similar in TG and WT animals (median DDCt values: 0.8 and 0.6, respectively). Although the AI was similar in the two groups, PI was significantly increased in TG than in WT mice (P ¼ 0.007) (Figures 5a-d) .
All WT mice showed more extensive inflammation (16.4 ± 7.8 vs 7.2 ± 4.6, P ¼ 0.01) often with numerous follicular inflammatory infiltrations localized in peribronchiolar, interstitial and subpleural areas (Figures 6a and b) . The twoway analysis of variance results, as performed by the GLM procedure, showed that interaction between SERPIN B3 General linear model analysis showed that interaction between SERPIN B3 expression and treatment was marginally significant (P ¼ 0.05). expression and treatment was significant for inflammation (P ¼ 0.05), supporting that the presence of SERPIN B3 may significantly decrease the BLM effect on inflammation (Figure 6c ). Even if not statistically significant, higher rates of neoplastic transformation foci were detected in TG than WT animals (10 and 40%, respectively).
DISCUSSION
This study presents in vivo evidence for a role of SERPIN B3 in inhibiting inflammation and favoring epithelial proliferation with increased TGF-b secretion, and likely consequent fibrogenesis. Although BLM may directly cause epithelial structural damage, 26 its principal mode of action in leading to IPF-like pathology seems to be via endogenous mediators of inflammation, fibrosis and proliferation. The BLMinduced lung injury in experimental models causes an extensive inflammatory background, sometimes with elective centrolobular localization. This model has been highly criticized as a representative model of human IPF. 27 However, to date, it represents the most used experimental reproduction of the disease. All our mice developed extensive lung damage after BLM treatment, with a prevalent inflammatory component already evident 48 h after injury. Interestingly, at 20 days, SERPIN B3 TG mice showed less evident inflammation, which could be related to an anti-inflammatory influence of SERPIN B3. Many clade B SERPINs are inhibitors of cathepsin (G, S, K, L), which have a well-known monocyte/granulocyte chemoattractant function. [28] [29] [30] At this time, all our animals developed well evident interstitial lung fibrosis after BLM treatment, which was significantly more extensive in SERPIN B3 TG mice. This finding reinforces our previous data obtained from the study of IPF lung samples wherein more extensive fibrosis was observed in patients with higher SERPIN B3/B4 expression. 13 Fibrotic remodeling could be related to the anti-inflammatory function of SER-PIN B3/B4 through the downregulation of cathepsins (although this was not statistically significant in our study) or to an increased secretion of TGF-b. In lung fibrosis, there is now considerable evidence that TGF-b has a pivotal role in the production of collagen and extracellular matrix 31 as well as in promoting epithelial-to-mesenchymal transition. 32 Overexpression of TGF-b has been detected in lungs of mice after BLM induction 33 and it seems to be more evident in our TG mice. The increased level of TGF-b detected in our model could be mainly due to an enhanced number of metaplastic epithelial cells, which have been demonstrated to be an important source of this cytokine in lung fibrosis. 13, 33 Indeed an SERPIN B3 and proliferation in mice F Lunardi et al of epithelial origin 34 and of the liver, 35 significantly attenuates apoptosis mediated by anti-cancer drugs or TNF-a, allowing tumor growth. 36 The molecular target location of SERPIN B3 in the apoptotic pathway has been suggested to be upstream from the caspase 3, as demonstrated in SCC Ag-1 and DNA transduced PCI-51 cells after TNF-a induction and in 293T cells genetically engineered for SERPIN B3 after radiation therapy. 37 Furthermore, SERPIN B3 has recently been indicated in the inhibition of UV-induced apoptosis through the suppression of c-jun N-terminal kinase. 38 At 48 h after BLM treatment (group T48 h), apoptotic cell death was equally balanced in WT and TG mice. At killing (group T20d), apoptosis persisted at the same level with a significant gain of epithelial proliferation in TG animals. In summary, this study provides in vivo evidence for a role of SERPIN B3 in reducing inflammation, influencing epithelial proliferation/apoptosis imbalance and likely favoring fibrogenesis. This experimental scenario looks like an advanced form of human IPF in which fibrotic remodeling is associated with uncontrolled epithelial proliferation and lung cancer.
Thereby overexpression or aberrant expression of SERPIN B3 may have an important role in pulmonary epithelial dysfunction of pulmonary fibrosis and could represent an interesting target for the development of new therapeutic strategies.
